Trading Members of the Exchange are hereby informed that effective from Friday, February 14, 2020, the Equity Shares of Chandra Bhagat Pharma Limited shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days:
|
Name of the company
|
Chandra Bhagat Pharma Limited
|
|
Registered Office:
|
323-F Bhagat Bhuvan,
Dr Ambedkar Road
Matunga (East), Mumbai 400019
Tel :91 22 2414 6154
Email: compliance@cbcpharma.net
Website: www.cbcpharma.com
|
|
No. of Securities
|
7545056 Equity Shares of Rs.10/- each fully paid up
|
|
Distinctive Number range
|
1 To 7545056
|
|
Scrip ID on BOLT System
|
CBPL
|
|
Abbreviated Name on BOLT System
|
CBPL
|
|
Scrip Code
|
542934
|
|
ISIN No.
|
INE07QQ01016
|
|
Market Lot
|
2000
|
|
Issue Price for the current Public issue
|
Rs. 51/- per share (Face Value of Rs. 10/- and premium of Rs. 41/-)
|
|
Date of Allotment in the public issue:
|
February 11, 2020
|
|
Pari Pasu
|
Yes
|
|
Financial Year
|
Mar-31
|
|
Lock in detail
|
As per Annexure I
|
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February 2000, securities of the Company will only be traded in Dematerialized form. Trades effected in this scrip will be in minimum market lot (i.e. 2000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of at least one month.
b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Friday, February 14, 2020 . For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c) The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.
d) The Market Maker to the issue as mentioned in the prospectus is given below:
|
Beeline Broking Limited
Office No. 1 To 3, Vishwa Complex,
First Floor Opp. Jain Derasar, Navrangpura Ahmedabad - 380009.
Contact Person: Mr. Vanesh Panchal;
Tel: +91 – 079 – 6817 4040;
Website: www.beelinebroking.com
E-mail: vanesh@beelinebroking.com
SEBI Registration No.: INZ000000638
|
e) The Registrar to the issue as mentioned in the prospectus is given below
f) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
|
a) At the company:
Payal Bansal
Company Secretary and Compliance Officer
|
Address:
323-F Bhagat Bhuvan,
Dr Ambedkar Road
Matunga (East), Mumbai 400019
Tel :91 22 2414 6154
Email: compliance@cbcpharma.net
Website: www.cbcpharma.com
|
|
b) At the Exchange:
Rupal Khandelwal
Senior Manager
|
Tel.: (91) 022 2272 8262
|
Rupal Khandelwal
Senior Manager
Thursday, February 13,2020 |